跳至主要内容
临床试验/DRKS00032985
DRKS00032985招募中Unknown

Protection against exercise-induced muscle damage by 8 weeks of Omega-3 supplementation in older adults. - PROTECT

German Institute of Human Nutrition Potsdam-Rehbrücke0 个研究点目标入组 44 人开始时间: 2024年1月30日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
65 Years 至 85 Years(—)
性别
All

入选标准

  • Age: 65-85
  • - BMI between 22-30 kg/m²

排除标准

  • - Active smokers
  • - Athletes
  • - Atrial fibrillation, known/past cardiac arrhythmias or heart attacks
  • - Arterial hypertension (resting blood pressure > 140/90 mmHg)
  • - Taking blood lipid-lowering drugs (statins), antiarrhythmics (such as flecainide, propafenone, amiodarone, dronedarone) and anticoagulant medications (such as Apixaban, Marcumar)
  • - Food intolerances/allergies to seafood or algae
  • - Taking dietary supplements containing polyunsaturated fatty acids, including omega-3 fatty acids
  • - Diagnosed with diabetes mellitus
  • - Presence of malignant neoplasms, HIV
  • - self-reported serious diseases of the cardiovascular system such as arteriosclerosis or advanced heart disease (NYHA grade =2 (New York
  • Heart Association” classification)), acute respiratory diseases or
  • severe chronic lung diseases (COPD; GOLD stage =2 (Global
  • Initiative for Chronic Obstructive Lung Disease” classification))
  • - self-reported severe liver, kidney or metabolic diseases, such as liver cirrhosis (Child Pugh Score =2) or renal insufficiency (stage =3)

研究者

发起方
German Institute of Human Nutrition Potsdam-Rehbrücke

相似试验